Johnson & Johnson (JNJ) Stock Score, Valuation & Financial Research
Johnson & Johnson is in the Healthcare sector and Drug Manufacturers - General industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 37/100.
Quick answer for JNJ
Johnson & Johnson currently has a Wall Street Score of 37/100. The stored market price is $265.58. Its financial score is 34/100. Its valuation score is 16/100. These figures are a research snapshot, not a buy or sell recommendation.
What Johnson & Johnson does
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.
JNJ financial snapshot
- Wall Street Score:
- 37/100
- Current price:
- $265.58
- Market capitalization:
- $640.02B
- Revenue:
- $97.93B
- Net income:
- $21.04B
- Free cash flow:
- $19.70B
- Cash:
- $20.42B
- Total debt:
- $11.69B
- EPS:
- 11.03
- P/E ratio:
- 24.1x
- Financial score:
- 34/100
- Valuation score:
- 16/100
- Revenue score:
- 22/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $19.70B, showing positive cash generation.
- The balance sheet shows $20.42B of cash versus $11.69B of total debt, leaving more cash than debt.
What the numbers mean
Its current valuation score is 16/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 34/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research JNJ
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.